Adrucil, Fluorouracil Newswire

Adrucil, Fluorouracil Newswire

Comprehensive Real-Time News Feed for Adrucil, Fluorouracil (generic).

Results 1 - 20 of 152 in Adrucil, Fluorouracil (generic)

  1. Metformin could one day be used to treat malignant tumorsRead the original story w/Photo

    Tuesday Jan 16 | PhysOrg Weblog

    A*STAR researchers have provided strong evidence, using patient tumor grafts, that metformin, a common diabetes drug, might help fight colorectal cancer in humans. Metformin's potential as a tumor-suppressing agent, to prevent the growth of breast, colon, lung and prostate cancers, has been demonstrated in pre-clinical studies.

    Comment?

  2. Ipsen Announces 13 Posters and 1 Oral Presentation at the 2018 ASCO Gastrointestinal SymposiumRead the original story

    Monday Jan 15 | Customer Interaction Solutions

    Ipsen today announced that irinotecan liposome injection , cabozantinib , lanreotide , and telotristat ethyl are the subject of 11 posters, along with 2 others focusing on patients living with neuroendocrine tumors, at the 2018 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium , January 18-20, 2018 in San Francisco versus placebo in patients with advanced hepatocellular carcinoma who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial. First Author: Ghassan Abou-Alfa, MD "Ipsen has a strong presence in oncology at ASCO-GI 2018 with 13 posters dealing with clinical outcomes in pancreatic cancer, advanced hepatocellular carcinoma, neuroendocrine tumors and carcinoid syndrome .

    Comment?

  3. Best time to assess complete clinical response after...Read the original story

    Friday Jan 12 | CiteULike

    Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus : a post-hoc analysis of randomised controlled phase 3 trial. Guidelines for anal cancer recommend assessment of response at 6-12 weeks after starting treatment.

    Comment?

  4. Treatment of the Primary Tumor in Anal Canal Cancers.Read the original story

    Friday Jan 12 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Radical concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C remains the standard of care for squamous cell carcinoma of the anus.

    Comment?

  5. Actinic Keratosis Treatment Market Projected to Grow Steadily Period 2017 - 2027Read the original story w/Photo

    Wednesday Jan 10 | SBWire

    Geographical location of a place is known to play a key role in development of this skin disease. Populations in countries closer to the Equator are more susceptible to be affected from AK that could eventually lead to SCC or BCC.

    Comment?

  6. Medicinal Cream May Help Stop Skin Cancer's ReturnRead the original story w/Photo

    Monday Jan 8 | MedicineNet

    For people who've battled certain common forms of skin cancer , use of a generic cream called 5-FU may greatly reduce the odds that the disease will come back, new research shows. The study tracked outcomes for just over 930 U.S. veterans who averaged 70 years of age.

    Comment?

  7. Cream May Keep Skin Cancer From ReturningRead the original story w/Photo

    Monday Jan 8 | News Max

    For people who've battled certain common forms of skin cancer, use of a generic cream called 5-FU may greatly reduce the odds that the disease will come back, new research shows. The study tracked outcomes for just over 930 U.S. veterans who averaged 70 years of age.

    Comment?

  8. Fluorouracil Sales, Price Analysis, & Sales Forecasts 2016-2021 - Research and MarketsRead the original story w/Photo

    Tuesday Jan 2 | Business Wire

    Find out the sales of Fluorouracil worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Fluorouracil by countries, and also find out sales forecast until 2021.

    Comment?

  9. Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cellsRead the original story w/Photo

    Thursday Dec 28 | BioMed Central

    Danshen is a common traditional Chinese medicine used to treat neoplastic and chronic inflammatory diseases in China. However, the effects of Danshen on human oral cancer cells remain relatively unknown.

    Comment?

  10. Impact of FOLFIRINOX compared with gemcitabine on quality of life in...Read the original story

    Dec 21, 2017 | CiteULike

    Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial. To compare the quality of life of patients receiving oxaliplatin, irinotecan, fluorouracil, and leucovorin or gemcitabine as first-line chemotherapy and to assess whether pretreatment QoL predicts survival in patients with metastatic pancreatic cancer.

    Comment?

  11. Serum cytokine profiles predict survival benefits in patients with...Read the original story w/Photo

    Dec 18, 2017 | BioMed Central

    Sorafenib is a multiple receptor tyrosine kinase inhibitor known to prolong overall survival in patients with advanced hepatocellular carcinoma . Predicting this drug's survival benefits is challenging because clinical responses are rarely measurable during treatment.

    Comment?

  12. Photosensitive lichenoid skin reaction to capecitabineRead the original story w/Photo

    Dec 18, 2017 | BioMed Central

    Capecitabine is an oral prodrug of fluorouracil, which is a common agent used in the management of many solid tumor malignancies. Dermatologic reaction is common with various chemotherapy agents but is not commonly reported in the use of capecitabine.

    Comment?

  13. Inhibition of autophagy enhances synergistic effects of Salidroside...Read the original story w/Photo

    Dec 15, 2017 | BioMed Central

    Various plant extracts have been suggested to be used as auxiliary agents in chemotherapy considering their anti-proliferative effect on cancer cells. However, recent reports reveal that plant extracts may function as inducers of autophagy of cancer cells.

    Comment?

  14. Managing Glaucoma with ICE SyndromeRead the original story w/Photo

    Dec 12, 2017 | Review of Ophthalmology

    In addition to corneal edema, ICE syndrome is commonly associated with iris abnormalities, including atrophy, stretch holes, nodules and pupillary distortion, and the incidence of secondary glaucoma is high. Iridocorneal endothelial syndrome, or ICE syndrome, is a primary abnormality of the corneal endothelium.

    Comment?

  15. The Fine Art of Repairing Bleb LeaksRead the original story

    Dec 12, 2017 | Review of Ophthalmology

    As every glaucoma surgeon knows, trabeculectomy blebs can be problematic. One reason for this is that blebs sometimes leak.

    Comment?

  16. Genentech researchers uncover epigenetic regulator of pancreatic cancer cellsRead the original story w/Photo

    Dec 11, 2017 | Medical News

    Genentech researchers have identified an enzyme that shifts pancreatic cancer cells to a more aggressive, drug-resistant state by epigenetically modifying the cells' chromatin. The study, which will be published December 11 in the Journal of Cell Biology , suggests that targeting this enzyme could make pancreatic cancer cells more vulnerable to existing therapies that currently have only limited effect against this deadly form of cancer.

    Comment?

  17. Managing Hypotony After TrabeculectomyRead the original story w/Photo

    Dec 11, 2017 | Review of Ophthalmology

    Trabeculectomy remains a mainstay in the management of glaucoma, despite problems frequently associated with it, such as hypotony. Leaving postoperative hypotony untreated can result in permanent visual damage, so it's crucial to be on the lookout for it and address it when it becomes apparent.

    Comment?

  18. Researchers identify epigenetic orchestrator of pancreatic cancer cellsRead the original story w/Photo

    Dec 11, 2017 | PhysOrg Weblog

    SUV420H2 is highly expressed in advanced, invasive regions of pancreatic adenocarcinoma, but is less prevalent in healthy regions of the tissue and early stage lesions that retain the epithelial cell marker E-cadherin . Credit: Viotti et al., 2018 Genentech researchers have identified an enzyme that shifts pancreatic cancer cells to a more aggressive, drug-resistant state by epigenetically modifying the cells' chromatin.

    Comment?

  19. Lilly's Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer StudyRead the original story w/Photo

    Dec 10, 2017 | BioSpace

    Eli Lilly and Company today announced top-line results from its Phase 3 RAINFALL study of CYRAMZAA in combination with cisplatin and capecitabine or 5-FU in the first-line treatment of patients with HER2-negative metastatic gastric or gastroesophageal junction adenocarcinoma. The trial met its primary endpoint of progression-free survival but did not improve overall survival , a secondary endpoint.

    Comment?

  20. Study protocol of HGCSG1404 SNOW study: a phase I/II trial of...Read the original story w/Photo

    Dec 7, 2017 | BioMed Central

    In Japan, S-1 plus cisplatin regimen has become a standard therapy for patients with advanced gastric cancer. Moreover, the S-1 plus oxaliplatin regimen is now a standard treatment.

    Comment?